Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Omega Therapeutics Inc
(NQ:
OMGA
)
1.280
+0.040 (+3.23%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Omega Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
October 15, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
September 17, 2024
From
Omega Therapeutics
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts
August 15, 2024
Via
Benzinga
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
August 14, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Expert Ratings For Omega Therapeutics
June 18, 2024
Via
Benzinga
4 Analysts Have This To Say About Omega Therapeutics
May 07, 2024
Via
Benzinga
Uber To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Wednesday
August 07, 2024
Via
Benzinga
OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
June 24, 2024
Former Merck veteran brings extensive expertise across corporate finance, business development and corporate licensing
From
Omega Therapeutics
Via
GlobeNewswire
How Is The Market Feeling About Omega Therapeutics?
January 26, 2024
Via
Benzinga
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
May 30, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024
From
Omega Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024
From
Omega Therapeutics
Via
GlobeNewswire
OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024
May 06, 2024
OMGA stock results show that Omega Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 23, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
April 09, 2024
From
Omega Therapeutics
Via
GlobeNewswire
OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023
March 28, 2024
OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
March 28, 2024
From
Omega Therapeutics
Via
GlobeNewswire
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
March 06, 2024
From
Omega Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in January 2024
January 09, 2024
Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.
Via
InvestorPlace
Nvidia, Spotify Lead Five Stocks Near Buy Points
January 06, 2024
Nvidia could make some noise with its CES presentation Monday.
Via
Investor's Business Daily
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 05, 2024
Via
Benzinga
Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
January 05, 2024
Tesla, Apple and Mobileye were key losers.
Via
Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 05, 2024
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.